Stay updated on Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page
- Check4 days agoChange DetectedThe Ukraine site entry in Zaporizhzhia Oblast was updated from Zaporizhzhia to Zaporizhzhya in the locations list, with the previous spelling removed and the new transliteration added.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page’s revision label was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a minor update to the page’s revision history.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small update to the study record's metadata.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page revision tag changed from v3.6.0 to v3.6.2, indicating an updated version of the page content. This is a maintenance update and does not modify study details or other visible content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe Study Details page now indicates recruitment is closed by displaying 'No longer looking for participants', and adds new help/join sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a heading formatting change for Intervention/Treatment and a Revision: v3.6.0 update.SummaryDifference0.1%

- Check62 days agoChange DetectedThe locations list updates the Kharkiv entry to Kharkiv Oblast, adding Kharkiv, Kharkiv Oblast, Ukraine, 61000, and the revision tag advances to v3.5.5.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.